Paul ORegan
Overview
Explore the profile of Paul ORegan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agnelli L, Villa A, Butt F, Duca M, Guidi A, Carapezza M, et al.
Tumori
. 2024 Apr;
110(5):304-308.
PMID: 38676437
The use of Digital Healthcare Products is leading to significant improvements in clinical practice. Herein, we discuss the development of PROACT 2.0 (Patient Reported Opinions About Clinical Tolerability v2.0), a...
2.
Cassidy N, ORegan P, Luo S, Chapman D, Jefferson I
Sensors (Basel)
. 2024 Feb;
24(4).
PMID: 38400456
Distributed optical fibre sensing (DOFS)-based strain measurement systems are now routinely deployed across infrastructure health monitoring applications. However, there are still practical performance and measurement issues associated with the fibre's...
3.
FionaOLeary , Coffey N, Burke F, Roberts A, ORegan P, Kirwan L, et al.
J Dent
. 2024 Feb;
144:104893.
PMID: 38373520
Objectives: Cystic Fibrosis is an autosomal recessive condition. It is a multisystem disease treated with a broad range of pharmacological therapies, diet and nutrition, and physiotherapy. Previous studies suggest that...
4.
Coffey N, OLeary F, Burke F, Kirwan L, ORegan P, Plant B, et al.
J Clin Periodontol
. 2024 Jan;
51(5):571-582.
PMID: 38233039
Aim: To investigate the prevalence of gingivitis and periodontitis, and the oral hygiene status of adults with cystic fibrosis (CF) in the Republic of Ireland. Materials And Methods: A case-control...
5.
McNally P, Lester K, Stone G, Elnazir B, Williamson M, Cox D, et al.
Am J Respir Crit Care Med
. 2023 Sep;
208(9):917-929.
PMID: 37703083
Clinical trials have shown that use of elexacaftor/tezacaftor/ivacaftor (ETI) is associated with improvements in sweat chloride, pulmonary function, nutrition, and quality of life in people with cystic fibrosis (CF). Little...
6.
Vagg T, Shanthikumar S, Ibrahim H, ORegan P, Chapman W, Kirwan L, et al.
J Cyst Fibros
. 2023 May;
22(4):598-606.
PMID: 37230808
The ongoing development and integration of telehealth within CF care has been accelerated in response to the Covid-19 pandemic, with many centres publishing their experiences. Now, as the restrictions of...
7.
ORegan P, Hoskins R, Grave C, Stevenson J, Frost H, Graham D, et al.
JCO Clin Cancer Inform
. 2023 Jan;
7:e2200137.
PMID: 36657092
Purpose: Matching patients with cancer to precision medicine clinical trials on the basis of their tumor genotype has the potential to improve outcomes for patients who have exhausted standard-of-care treatment...
8.
Frost H, Graham D, Carter L, ORegan P, Landers D, Freitas A
Br J Cancer
. 2022 Aug;
127(8):1557-1564.
PMID: 35941175
Background: Molecular Tumour Boards (MTBs) were created with the purpose of supporting clinical decision-making within precision medicine. Though in use globally, reporting on these meetings often focuses on the small...
9.
Burke H, Freeman A, ORegan P, Wysocki O, Freitas A, Dushianthan A, et al.
BMJ Open
. 2022 Feb;
12(2):e050331.
PMID: 35168965
Objectives: COVID-19 is a heterogeneous disease, and many reports have described variations in demographic, biochemical and clinical features at presentation influencing overall hospital mortality. However, there is little information regarding...
10.
Zhang B, Buendia R, Iannoti N, Ramsden E, ORegan P, Swift J, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2021 Dec;
2021:4994-4997.
PMID: 34892329
With the rise of digital transformation in the pharmaceutical industry, digital therapeutics are being integrated in drug development clinical trials. In the TWINKLE study, information about asthmatic patients' disease control...